Additionele informatie

Project: The LEAP (Longitudinal European Autism Project) is an accelerated longitudinal study that enrolls 400 patients with autism and 250 typically developing controls diverse in age (6-30 years) and ability level at 7 sites in Europe. The study is part of the EU-AIMS programme (www.eu-aims.eu) that is sponsored by the Innovative Medicines Initiative Joint Undertaking under grant agreement number 115300 (EU-AIMS), resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007 – 2013) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) companies’ in kind contribution. The data include structural MRI, resting-state MRI, diffusion-weighted MRI, bold-response to tasks (social /non-social reward anticipation, theory of mind, and executive functioning), social and non-social cognition, EEG, biochemistry and DNA. The overall aim is to identify the neural, neurocognitive, genetic, and biomarker mechanisms underlying autism and parsen heterogeneous autism into biologically more homogenous subgroups.

Tasks: analyze existing resting-state MRI and/or DTI data, and publish in high-impact peer-reviewed journals.          

A completed PhD in neuroscience, psychology, neurobiology or medicine. Extensive experience in analyzing one of more of the following type of data: MRI data (structural MRI and/or resting-state MRI and/or diffusion-weighted MRI, and/or fMRI). Further, you should have an interest in neuropsychiatric disorders as autism. Finally, you have shown to have excellent and efficient writing skills and be able to publish in high-impact journals.

Scale 10: max. € 56801 gross income per year at full employment (incl. vacation bonus and end of year payments)

The Radboud university medical center advances human knowledge by conducting biomedical, translational and clinical research in order to improve wellbeing.

Our key strength is medical life-sciences and clinical practice, with an impressive infrastructure comprising state-of-the-art technology platforms and (translational) research facilities. The Radboud university medical center is therefore uniquely positioned in the emerging Euregio and Dutch healthcare infrastructure to play a leading role in the new healthcare paradigm of prediction, prevention and personalised medicine.

The Radboud university medical center focuses on scientific health challenges of today, with an eye on emerging diseases of the future.

Our mission: ‘to have a significant impact on healthcare’.

The Donders Centres for Neuroscience (DCN) and for Cognitive Neuroimaging (DCCN) are research centres of the Donders Institute for Brain, Cognition and Behaviour. The Donders Institute for Brain, Cognition and Behaviour is a leading centre of research expertise with a strong international reputation. We are a relatively new institute with an enterprising spirit and an excellent track record of research on Brain, Cognition and Behaviour. Our scientific output is prolific and renowned for its quality. Over 500 researchers work here on unravelling the mechanisms of the brain. Thanks to the integration of basic sciences in the institute, there is also a strong theoretical approach. Our research focuses on cognition and behaviour in humans as well as on the neuronal substrate, including the genetic, molecular and cellular processes that underlie cognition and behaviour.

For more information please contact :

(These e-mail addresses are to be used for information purposes only. Use the ‘Apply’ button to apply for the position.)